Aspirin in Colorectal Cancer Liver Metastases

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

466

Participants

Timeline

Start Date

December 15, 2017

Primary Completion Date

February 1, 2022

Study Completion Date

June 30, 2026

Conditions
Colorectal Cancer Liver MetastasesColorectal CancerLiver Metastases
Interventions
DRUG

Acetylsalicylic acid

Trombyl 160 mg once daily

DRUG

Placebo Oral Tablet

Placebo one tablet daily

Trial Locations (14)

Unknown

Aarhus University Hospital, Aarhus

Rigshospitalet, Copenhagen, Copenhagen

Odense University Hospital, Odense

Haukeland University Hospital, Bergen

Oslo University Hospital, Oslo

Stavanger University Hospital, Stavanger

University Hospital of North-Norway, Tromsø

St Olavs Hospital, Trondheim

Sahlgranska University Hospital, Gothenburg

Linköping University Hospital, Linköping

Skåne University Hospital Lund, Lund

Karolinska University Hospital, Stockholm

Uppsala University Hospital, Uppsala

University Hospital of Umeå, Umeå

All Listed Sponsors
collaborator

Norwegian Cancer Society

OTHER

collaborator

The Research Council of Norway

OTHER

collaborator

Klinbeforsk

OTHER

lead

Oslo University Hospital

OTHER

NCT03326791 - Aspirin in Colorectal Cancer Liver Metastases | Biotech Hunter | Biotech Hunter